Neuromodulation : Journal of the International Neuromodulation Society
-
Publication Venue For
- Prevalence and Cost Analysis of Chronic Pain After Hernia Repair: A Potential Alternative Approach With Neurostimulation. 2018
- A Feasibility Study of Percutaneous Peripheral Nerve Stimulation for the Treatment of Postoperative Pain Following Total Knee Arthroplasty. 2018
- Prevalence and Cost Analysis of Complex Regional Pain Syndrome (CRPS): A Role for Neuromodulation.. 21:423-430. 2018
- Down the Rabbit Hole: Specialty Influence on SCS Outcomes.. 21:417-420. 2018
- Field Distribution of Transcranial Static Magnetic Stimulation in Realistic Human Head Model.. 21:340-347. 2018
- Drivers and Risk Factors of Unplanned 30-Day Readmission Following Spinal Cord Stimulator Implantation.. 21:87-92. 2018
- Through the Looking Glass: Specialty Influence on SCS Outcomes.. 20:740-741. 2017
- Explantation Rates and Healthcare Resource Utilization in Spinal Cord Stimulation.. 20:331-339. 2017
- Impact of Insurance Provider on Overall Costs in Failed Back Surgery Syndrome: A Cost Study of 122,827 Patients.. 20:354-360. 2017
- Specialty-Based Variations in Spinal Cord Stimulation Success Rates for Treatment of Chronic Pain.. 20:340-347. 2017
- The Neurostimulation Appropriateness Consensus Committee (NACC): Recommendations on Bleeding and Coagulation Management in Neurostimulation Devices. 20:407-407. 2017
- The Volume-Outcome Effect: Impact on Trial-to-Permanent Conversion Rates in Spinal Cord Stimulation.. 20:256-262. 2017
- The Neurostimulation Appropriateness Consensus Committee (NACC) Recommendations for Infection Prevention and Management.. 20:31-50. 2017
- The Neurostimulation Appropriateness Consensus Committee (NACC) Safety Guidelines for the Reduction of Severe Neurological Injury.. 20:15-30. 2017
- The Neurostimulation Appropriateness Consensus Committee (NACC): Recommendations on Bleeding and Coagulation Management in Neurostimulation Devices.. 20:51-62. 2017
- Longer Delay From Chronic Pain to Spinal Cord Stimulation Results in Higher Healthcare Resource Utilization.. 19:469-476. 2016
- Implantable Neurostimulation for Headache Disorders: Effect on Healthcare Utilization and Expenditures.. 19:319-328. 2016
- Automatic Vagus Nerve Stimulation Triggered by Ictal Tachycardia: Clinical Outcomes and Device Performance--The U.S. E-37 Trial.. 19:188-195. 2016
- Comparison of Bilateral vs. Staged Unilateral Deep Brain Stimulation (DBS) in Parkinson's Disease in Patients Under 70 Years of Age.. 19:31-37. 2016
- The Incidence of Spinal Cord Injury in Implantation of Percutaneous and Paddle Electrodes for Spinal Cord Stimulation.. 19:85-90. 2016
- COMMENTS. 18:703-704. 2015
- A national survey of spinal cord stimulation trial-to-permanent conversion rates.. 18:133-139. 2015
- The Rationale Driving the Evolution of Deep Brain Stimulation to Constant-Current Devices. 18:85-89. 2015
- A national survey of spinal cord stimulation trial-to-permanent conversion rates. 18:133-139. 2015
- Comments. 18:149. 2015
- The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the Neuromodulation Appropriateness Consensus Committee.. 17:515-550. 2014
- The appropriate use of neurostimulation: stimulation of the intracranial and extracranial space and head for chronic pain. Neuromodulation Appropriateness Consensus Committee.. 17:551-570. 2014
- Spinal cord stimulation for intercostal neuralgia in a patient with implantable cardiac defibrillator and biventricular pacing.. 17:386-388. 2014
- Surgical Paddle-Lead Placement for Screening Trials of Spinal Cord Stimulation. 17:346-348. 2014
- Comment. 17:235. 2014
- Comments. 17:441. 2014
- Comments. 17:47. 2014
- Investigation of deep brain stimulation mechanisms during implantable pulse generator replacement surgery. 17:419-424. 2014
- Rehospitalization and Emergency Department Use Rates Before and After Vagus Nerve Stimulation for Epilepsy: Use of State Databases to Provide Longitudinal Data Across Multiple Clinical Settings. 17:60-65. 2014
- Insurance disparities in the outcomes of spinal cord stimulation surgery. 16:428-434. 2013
- Outcomes of percutaneous and paddle lead implantation for spinal cord stimulation: a comparative analysis of complications, reoperation rates, and health-care costs.. 16:418-426. 2013
- Safety in the Use of Dexmedetomidine (Precedex) for Deep Brain Stimulation Surgery: Our Experience in 23 Randomized Patients. 16:401-406. 2013
- Safety in the Use of Dexmedetomidine (Precedex) for Deep Brain Stimulation Surgery: Our Experience in 23 Randomized Patients COMMENTS. 16:406-406. 2013
- Comments. 16:225. 2013
- Outcomes of Percutaneous and Paddle Lead Implantation for Spinal Cord Stimulation: A Comparative Analysis of Complications, Reoperation Rates, and Health-Care Costs 2013
- Spinal cord stimulation therapy for patients with refractory angina who are not candidates for revascularization.. 15:550-558. 2012
- Spontaneous resolution of nausea induced by spinal cord stimulation for failed back surgery syndrome. 13:292-295. 2010
- Socioeconomic Trends in Deep Brain Stimulation (DBS) Surgery.. 13:182-186. 2010
- A socioeconomic survey of spinal cord stimulation (SCS) surgery. 13:265-269. 2010
- Functional electrical stimulation for control of internal organ function: Commentary. 4:161-162. 2001
- Preclinical toxicity study of intrathecal administration of the pain relievers dextrorphan, dextromethorphan, and memantine in the sheep model. 2:230-240. 1999